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ABSTRACT 
With the increasing availability of wearable devices, continuous 
monitoring of individuals’ physiological and behavioral patterns 
has become significantly more accessible. Access to these 
continuous patterns about individuals’ statuses offers an 
unprecedented opportunity for studying complex diseases and 
health conditions such as type 2 diabetes (T2D). T2D is a widely 
common chronic disease that its roots and progression patterns 
are not fully understood. Predicting the progression of T2D can 
inform timely and more effective interventions to prevent or 
manage the disease. In this study, we have used a dataset related 
to 63 patients with T2D that includes the data from two different 
types of wearable devices worn by the patients: continuous 
glucose monitoring (CGM) devices and activity trackers 
(ActiGraphs). Using this dataset, we created a model for 
predicting the levels of four major biomarkers related to T2D 
after a one-year period. We developed a wide and deep neural 
network and used the data from the demographic information, 
lab tests, and wearable sensors to create the model. The deep part 
of our method was developed based on the long short-term 
memory (LSTM) structure to process the time-series dataset 
collected by the wearables. In predicting the patterns of the four 
biomarkers, we have obtained a root mean square error of 
±1.67% for HBA1c, ±6.22 mg/dl for HDL cholesterol, ±10.46 
mg/dl for LDL cholesterol, and ±18.38 mg/dl for Triglyceride. 
Compared to existing models for studying T2D, our model offers 
a more comprehensive tool for combining a large variety of 
factors that contribute to the disease.     
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1 Introduction 
Diabetes mellitus refers to a group of chronic metabolic diseases 
resulting from problems in the production and processing of 
insulin production and functionality. Among various types of 
diabetes, the most common is type 2 (T2D), related to the 
condition that the cells are unable to respond adequately to 
normal levels of insulin (insulin resistance). In 2014, 8.5% of 
worldwide adults were diagnosed with some type of diabetes. 
With close to 90% of the diabetic patients diagnosed with T2D, 
the number of individuals with T2D has reached close to 380 
million in 2014 and expected to exceed 450 million in 2030 [1]. In 
diabetic patients, the blood glucose levels (a critical indication of 
the body’s normal condition) can exceed from its safe level. Over 
time, this can result in serious damages to major organs such as 
eyes and diseases such as cardiovascular disease. Lifestyle has 
been shown to significantly affect the risk of T2D and its 
progression patterns [2]. T2D requires constant management 
and care, and the progressive nature of the T2D makes this 
management and care very challenging. This constant care 
includes diet management, physical exercises, drug therapy, and 
insulin delivery. 
Various factors are believed to determine the progression 
patterns of T2D. The short-term blood sugar concentration is 
one of the most important indexes for the providers to estimate 
the progression of the disease [3]. The blood glucose level can 
function as a momentary indicator for the overall state of a 
diabetic patient, and Glycated hemoglobin (HbA1c) is generally 
being used among medical researchers as a criterion for long 
term progression of the disease [4]. Considering the importance 
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of effective control and management of T2D, modeling the 
progression of this disease can have a great impact on improving 
the effectiveness of interventions on patients with diabetes 
specifically if applied early enough. This type of timely 
intervention can be achieved through early identification of the 
changes in the pattern of the disease and possibly lead to 
decreasing the progression pace of the disease, and consequently 
expanding the life expectancy of patients.  
Machine learning (ML) techniques offer great tools for modeling 
the progression of T2D. Among various forms of ML techniques 
that have been used for studying chronic diseases [5], the family 
of deep learning models is especially well suited for modeling 
the progression of T2D. This is mainly due to their ability to 
effectively identify the complex patterns among a large set of 
risk factors features. The complex nature of T2D is partly 
because of the various factors that contribute to the disease. To 
create models that can effectively capture the complete picture 
of T2D progression, it is crucial to have access to the datasets 
that contain many representatives of these various factors. 
Wearable sensors offer a great tool to capture rich datasets 
containing continuous (longitudinal) physiological signals.  
In this study, we have used a dataset from two types of wearable 
sensors. The first one was Continuous Glucose Monitoring 
(CGM) that has revolutionized the process of monitoring blood 
glucose in recent years. CGM is a wearable non-invasive device 
that measures the glucose concentration of the blood in 1 to 5 
minutes intervals, and therefore can effectively capture the 
fluctuations in blood glucose levels [6]. The second source of 
wearable sensor data in this project was a set of activity 
monitoring sensors. Generally, these wearable sensors are placed 
on the wrist or hip of an individual and monitor physical his/her 
movements in three-dimensional space. While these wearable 
sensors collect rich information from patients, wearing them for 
a long period can be unpleasant and impractical. As daily 
activities result from routines that are imposed by fixed 
environmental factors such as group paternal behaviors and 
individual habits [7], it is expected to observe some degree of 
consistency in time, duration, and types of activities of a person 
over a year. This consistency can help the progression prediction 
process to rely on the smaller wearable monitored dataset and 
reduce the length of the required monitoring process. 
While various attempts have been made to model the 
progression of T2B, we are not aware of any study that has used 
longitudinal wearable sensors data in combination with other 
types of discretely sampled datasets (such as lab tests) to model 
T2D. Specifically, the main contributions of our study are: 
      1) We have developed a model to predict the progression of 
T2D using demographic, lab tests, and wearable sensor data.  
      2) By evaluating our model on data collected from real T2D 
patients, we have shown that by monitoring the wearable CGM 
and activity sensed signals over a short period of time as time-
series signals, we can predict patients’ diabetic status in one 
year.  
2 Related Works 
Applying machine learning (ML) techniques to diabetes 
problems has been an active research area in recent years. While 
these studies differ in methodology and application, they all to 
some degree try to model the progression of T2D in various 
stages of the disease development. HbA1c is a widely used 
standard measure for estimating the progression of T2D and 
determining the effectiveness of a treatment, and some studies 
tried to combine this with other biomarkers that can predict T2D 
patterns. For instance, Bagherzadeh et al. [8] have provided a 
new method for identifying an optimal set of predictors of T2D 
using the wrapper method as a feature selection algorithm. In 
another study, George et al. [9] used a variant of Random Forests 
method to estimate the accuracy difference resulted by selecting 
various features to predict blood sugar concentration in T1D 
patients. Simon et al. [10] used unsupervised association rules to 
derive the connections between diabetes risk factors.  
ML-based methods have been also used to detect the likelihood 
of diabetes incidence for a non-patient or model the disease 
progress of the disease for diagnosed patients over a certain 
period. This problem has been mostly considered as a 
classification problem in the literature. In a survey study, 
Kavakiotis et al. [5] have compared different prediction methods 
in five diabetes studies. These methods were Logistic Regression, 
Naive Bayes, Linear Discriminant Analysis, Random Forest, 
Artificial Neural Networks, and Support Vector Machines. They 
showed that by selecting a similar set of features, SVM leads to 
the best prediction performance. In another study, Casanova et 
al. [11] presented a method based on Random Forests and 
demonstrated the higher robustness of their method against 
overfitting versus other comparable techniques in diabetes 
prediction. Specifically, their classification with Random Forests 
outperformed Logistic Regression in exploiting all the 93 
features that were collected from 3600 African-American 
patients over a period of 8 years. Ensemble techniques to 
combine multiple learning methods to improve the classification 
performance has been also used in diabetes research. Anderson 
et al. [12] used a Bayesian scoring algorithm to model the space 
of events for a diabetes patient. Ozcift et al. [13] used Rotation 
Forests as the ensemble method to combine 30 ML algorithms for 
medical diagnosis on several diseases including diabetes. 
Additionally, identifying the short- and long-term complications 
of Diabetes has been the topic of several studies. Many studies 
have focused on modeling the complex relations between 
diabetes and other conditions such as high blood pressure and 
obesity to chronic diseases such as Alzheimer’s, cancer, 
obstructive sleep apnea, and eye damage [5]. For instance, 
Sudharsan et al. [14] used SVM and random forests to predict the 
occurrence of hypoglycemia (low blood sugar) among T2D 
patients, and San et al. [15] utilized heart rate signals using a 
deep learning framework to model the occurrence of 
hypoglycemia in children diagnosed with T1D. Ibrahim et al. 
[16] combined fuzzy logic classifiers and a clustering method to 
classify diabetic eye damage. 
Among various types of ML methods used in the diabetes 
research domain, deep learning-based methods have received a 
lot of attention. In studying chronic conditions like diabetes, 
 processing the sequential time-series data can be done using 
Recurrent Neural Networks (RNNs). RNNs are a family of deep 
neural networks that can extract dynamic temporal patterns 
from a given data sequence. For instance, for diagnosis 
applications, Lipton et al. [17] were one of the first to show the 
higher accuracy of LSTM-RNN for a classification task of time-
series clinical/healthcare data by comparing the performance of 
the model with a multi-layer perceptron hand-engineered 
classifier. Choi et al. [7] used the clinical visit records of the 
patients in an RNN (Gated Recurrent Units) model to predict 
their most likely diagnoses and treatment. Their method showed 
a higher performance compared to Logistic Regression and 
multi-layer perceptron on the same dataset. Swapna et al. [18] 
used Heart Rate Variability (HRV) data analysis to diagnose 
diabetes using deep learning techniques. They achieved an 
accuracy of 95% using a 5-LSTM CNN with SVM. Specifically, 
this type of methods is still new to the area of T2D research. 
3 Dataset 
The dataset that was used in this study is collected by the co-
authors at the University of Delaware and in collaboration with 
the Christiana Care Health System in DE, USA. All procedures 
for accessing and analyzing the data from this study was 
approved by the University of Delaware Institutional Review 
Board. The data was obtained from a group of patients diagnosed 
with T2D as part of a year-long study. The main study focused 
on psychological, behavioral, and interpersonal patterns among 
T2D patients and their spouses, and the role of collaborations 
between the couples coping with the disease complications. The 
T2D patients were in 33-78 years old age range. The records of 
the patients' non-diabetic spouses were not used in this current 
work. For each patient, various types of data were collected, 
including a baseline assessment involving clinical questionnaires 
and blood and urine tests. After seven days, the daily diary data 
were collected from the wearable devices that were given to the 
participants at the time of finishing the baseline measurements. 
A second blood and urine sample were collected one year after 
the baseline assessment. Three major components of this	dataset	are	presented	in the following.  
3.1 CGM Measurements 
In the baseline assessment visit of the study, each patient was 
equipped with a Dexcom G4 Platinum Professional CGM 
device. Each patient was trained on operating the device (e.g., 
how to wear the sensors and the proper care to obtain reliable 
readings). The CGM monitored the glucose level of each subject 
for seven consecutive days and recorded the glucose levels in 
five-minute intervals. The collected data by the end of the 
seven-day period contained between 1445 to 2016 consecutive 
CGM measurements for each patient. Out of the 63 patients in 
our dataset, 9 did not have any record for their second HbA1c 
measurement, and therefore could not be used in evaluating 
the performance of our models. Moreover, 4 participants had a 
significantly smaller number of CGM measurements compared 
to others. Since the length of the time-series input needed to be 
fixed in our model, these small sequences would enforce a big 
portion of other sequences to be cut. Therefore, we decided to 
remove these 4 records as well. As a result, 50 sequences of 
CGM remained for evaluation. The CGM series of data were all 
shortened to the size of the smallest one which was 1445. 
Therefore, the dimensions of the CGM data were [50×1445×1]. 
3.2 ActiGraph Data 
During the same seven consecutive days of collecting the CGM 
measurements, body movements and physical activity patterns 
of the patients were recorded as well. Each patient wore an 
ActiGraph device on his/her non-dominant wrist. ActiGraph 
recorded the physical movements of each subject in three 
dimensions of the space (x, y, and z). We have used the ActilLife 
software (the commercial software provided by the manufacture 
of ActiGraph) to initially process the raw data into interpretable 
information for each patient. To include enough information 
about activity signal patterns, we have chosen 30 seconds as the 
activity processing epoch. This means that the ActiLife software 
divided the entire duration of data recording into 30 second 
intervals and extracted the physical activity information on each 
of those intervals. In the measured vector, the first three values (𝐷#,𝐷%,𝐷&) were the aggregated physical movements in each of 
the three coordinates in the corresponding interval. The fourth 
value (𝑆)  was the calculated traveled steps. The next three 
values (𝐼*+, , 𝐼*,-, 𝐼.+/) were inclinometer indicators, where sitting, 
standing, and lying activity times are saved in their 
corresponding fields. The eighth field ( 𝐼011 ) shows the 
undetected activity moments of a subject at a given interval. 
Therefore, the activity data of a subject can be presented by an 
eight-field vector for every 30 seconds. 
3.3 Demographic and Lab Test Data 
In addition to the above data, a rich set of demographic and 
clinical information was collected from each subject twice over 
the course of the study. At baseline (beginning of the one-year 
study), body weight, height, and waist circumference were 
measured for each participant. Participants went through lab 
blood tests and their biomedical indexes were recorded. These 
biomedical indexes included HbA1c, cholesterol, triglycerides, 
HDL cholesterol, LDL cholesterol, non-LDL cholesterol, and 
VLDL cholesterol. Also, urine samples were examined to 
determine creatinine and microalbumin levels. One year after the 
baseline assessment, these biomedical indexes were remeasured. 
As a criterion for the degree of T2D severity, HbA1c is an 
accepted standard, and the improvement/deterioration tracing of 
the disease could be determined using the HbA1c levels.  
4 Methodology 
The proposed framework follows a wide and deep structure to 
utilize the inherently different types of data that we had in this 
dataset with the goal of boosting the prediction performance. 
Deep neural networks (here in the form of RNN) are useful in 
learning the patterns from time-dependent values of the signals. 
 
 
The wide and deep model [19] co-trains a deep learning network 
with a linear model. This method was selected for this study as 
we wanted to combine demographic data and lab tests with 
continuous time-series information. The deep part relies on 
time-varying value changes patterns of CGM and ActiGraph, 
and the wide part considers the other measured data for each 
patient. The idea was to effectively balance the information from 
each part, and use demographic data and lab test results of the 
patients, coupled with the features that have been extracted from 
the time-series wearable data to predict the HbA1c value change.  
Figure 1 shows an overview of the proposed predictive 
framework for HbA1c estimation. In this framework, the activity 
data was first transformed into a sequence of moving averages 
and then it was merged with the CGM sequence. In the 
following sections, we explain the procedure that was used in 
each of the components of this wide and deep framework. 
 
Figure 1: The Wide and Deep learning network used in this 
study. 
4.1 Signal Synchronization 
As shown in Figure 1, two signals of wearable measurements 
(CGM and ActiGraph) must be synchronized prior to using them 
in the learning network. Both CGM and ActiGraph data 
collection took place during the same seven-day period. There 
are two challenges regarding the measurement of time points in 
these two value sequences. First, the exact starting point of data 
measurements for the two signals did not match. Second, the 
CGM recordings were collected much more frequently compared 
to the activity ones. To be able to have a consistent time-series 
signal that carries meaningful patterns of patients’ physiological 
information, these signals should have been first synchronized. 
Assuming the measurement time points (𝑡+), the CGM signal (𝑆3)  may consist of n (1445<n<2016) number of 𝐶,5 
measurements, where the number of measurements varied for 
different patients can be shown as: 𝑆3 = 7𝐶,8,…𝐶,:;. Similarly, 
for the ActiGraph signal (𝑆<), m (15653<m<20160) number of 𝐴>5 
measurements were available, and can be shown as: 𝑆< = 7𝐴>8, …𝐴>?;	 
Since the number of measured values for both CGM and 
ActiGraph was not fixed among the patients, each patient had 
a different pair of 𝑚 and 𝑛. The following six steps were taken 
to generate synchronized CGM/ActiGraph signals for each 
patient by utilizing a moving average with overlapping windows 
method. (1) All of the CGM measurement time points 𝑡+ s, 
without any recorded ActiGraph measurement before and after 
them were removed. This resulted in excluding the CGM 
measurements that could not have an activity signal alongside 
them. (2) From the remaining 𝑡+s, the earliest time point was 
selected (i=1). (3) The closest activity-measured time point was 
then detected (shown as 𝜃D in Figure 2). (4) The 𝑊𝑖𝑛𝑑𝑜𝑤+ of 
|W| activity measurements was formed. This window contained 
|W| closest activity time points to 𝑡+ . This way the average 
activity vector (𝐴,JKKKK) was calculated as: 𝐴,JKKKK = 𝐴𝑣𝑒𝑟𝑎𝑔𝑒Q𝐴>RS , 	𝑤ℎ𝑒𝑟𝑒	𝜃D	 ∊ 𝑊𝑖𝑛𝑑𝑜𝑤+	 
 
 
Figure 2: Sensor measurements time points, and the 
window for averaging the activity measurements. 
 (5) Having the average activity vector (𝐴,JKKKKK), the combined 
synchronized CGM/ActiGraph value in time point 𝑡+  was 
obtained in a format of: 𝐶𝐴𝑡𝑖 = 𝐶𝑡𝑖 , 𝐴𝑡𝑖̅ . (6) To derive the next 
value for the merged time-series signal, the succeeding 
measured time point was found (i=i+1), and the above 
procedure was iteratively continued starting from the Step (2). 
In this study, we selected 50% as the overlap ratio (the portion 
of a window that is included in next consecutive measurement) 
to balance the time-series data dependency with the 
information loss of averaging the activity data. Considering the 
timing distance of the two measurements (5 minutes for CGM, 
and 30 seconds for ActiGraph), the window size |𝑊| could be 
calculated as: |𝑊| = (|𝑡+WX − 𝑡+|/|𝜃DWX − 𝜃D|𝑜𝑣𝑒𝑟𝑙𝑎𝑝	𝑟𝑎𝑡𝑖𝑜 ) = Q5𝑚𝑖𝑛𝑠30𝑠𝑒𝑐𝑠S50% = 20 
Having the merged and synchronized time-series wearable 
signal, we then used them in our deep learning network. 
 
 
Figure 3: (a) The structure of the LSTM RNN used for 
learning the patterns of the wearable data, (b) The 
architecture of the auxiliary network used between the 
RNN and output layers of our model. 
4.2 Long Short-Term Memory Network 
Long short-term memory (LSTM) units are a specific type of 
RNNs that can analyze and classify a sequence of temporal data 
 signals of any length. An LSTM unit consists of input, output, 
memory, and forget gates. The memory gates of an LSTM can 
remember the values over time. The other three gates are similar 
to general neuron nodes with weighted connections and an 
activation function. Because of their memorization capability, 
LSTM networks can be used to process and learn time-series 
signals where the sequential data points are correlated. 
The proposed architecture of the RNN model consists of one 
input layer, two hidden layers of LSTM blocks, and one output 
layer (Figure 3.(a)). The input layer consists of N LSTM units for 
N time points in the time-series CGM/ActiGraph signal. Here, 
the input gate of the ith LSTM unit will be connected to the 
signal value at the time point 𝑡+ (𝐶𝐴,5), which is a row vector 
with 9 features as the input of each LSTM unit. We can 
formulate the prediction function as: ∆e𝐻𝐵𝐴1𝐶 = 𝑓(𝐶𝐴,8, 𝐶𝐴,j,… , 𝐶𝐴,k) 
where the output  ∆e𝐻𝐵𝐴1𝐶  is the estimated change of a 
patient’s HbA1c after one year, and the function f represents the 
proposed model. 
The desired output of the function f is a single value of ∆e𝐻𝐵𝐴1𝐶. However, the output of the RNN network is a time-
series signal. This time-series signal should be converted to the 
format of a logistic regression function to obtain the desired 
output format. Therefore, an auxiliary network was used to 
process the outputs of the LSTM network (Figure 3.(b)). In this 
architecture, N time-series outputs of the LSTM network were 
connected to 100 sigmoid activation blocks (S) of the first hidden 
layer of the output architecture. These 100 blocks were then 
connected to 50 other sigmoid activation blocks (S) in the second 
hidden layer. Finally, these blocks were linked to a linear block 
(Σ) to generate the output of the deep part.  
4.3 Learning from Demographic Data and Lab 
Test Results  
The demographic data and lab test results of the patients were 
then added to our deep model. The related features included:  1) 
height, 2) weight (kg), 3) age (years), 4) waist circumference (m), 
5) Triglycerides (TC, mg/dL), 6) LDL cholesterol (mg/dL), 7) HDL 
cholesterol (mg/dL), and 8) VLDL cholesterol (mg/dL) of the 
patients. As these values for features were recorded at the 
baseline of the experiment, each feature had a single value for 
each patient and did not have any time-dependent component. 
To learn from this data, a logistic regression model was used 
forming the wide part of our proposed model.  
5 Model Evaluation 
All of the experiments were run on the Tensorflow platform [20] 
with Keras neural-network library [21]. To combine the wide 
network with the deep part, the Linear Combined Classifier in 
Tensorflow was used. This library offers a general framewrok for 
implementing wide and deep structures. To compare the 
performance of different parts of our model, we have performed 
a set of experiments using 1) only the demographics and lab test 
data, 2) only the CGM data, CGM and ActiGraph data, and 3) 
using the full dataset containing the wearable, demographics and 
lab test data. The models were evaluated in both regression and 
classification settings. The regression task refers to predicting 
the value of HbA1c difference, and the classification task refers 
to predicting whether the HbA1c value was increased or 
decreased. In the case of classification, the two classes of changes 
in HbA1c value were assumed as: 1) Improvement: ∆HbA1c≤ 0, 
and 2) Deterioration: ∆HbA1c>0. Beside HbA1c, which is the 
primary indicator of the state of T2D, we have also used our 
model to predict several other key biomarkers that are generally 
considered important in T2D control.  
Estimating HbA1c using Demographic and Lab Test 
Results – In this step, the wearable sensor measurements were 
disregarded, and the prediction was made based on the 
demographic data and blood lab test results. For measuring the 
accuracy of the regression tasks (predicting the difference in 
HbA1c), we used the Root Mean Squared Error (RMSE) defined 
as: 𝑅𝑀𝑆𝐸 = sqrt(∑ 7∆e𝐻𝐵𝐴1𝐶 − ∆𝐻𝐵𝐴1𝐶;tu+vX 𝑁 ) 
where  ∆𝐻𝐵𝐴1𝐶 is the measured change in patients HbA1c, ∆e𝐻𝐵𝐴1𝐶 is the predicted change in HbA1c, and N is the number 
of predicted records. The size of the input data in this 
experiment was [50×8] as we had 50 patients and 8 
measurements for each. The prediction led to an RMSE of 2.444 
with a standard deviation of σ=0.302. Since RMSE is a range 
dependent metric, the value ranges in the dataset are also 
provided to illustrate the quality of each resulted RMSE. For each 
biometric parameter such as HbA1c, the value range is equal to 
the difference between the maximum and minimum monitored 
values between all the patients. For the binary classification, an 
accuracy of 74.87% was obtained. 
Estimating HbA1c using CGM Only – In this experiment, the 
RNN network was trained using the CGM signals. As previously 
described, the dimensions of the CGM data were [50×1445×1], as 
we had 1445 CGM recordings for each patient. For this 
experiment, we used 50 epochs for training and 5-fold cross 
validation, and obtained an average of RMSE=1.772 (σ=0.138). 
Additionally, the accuracy achieved for the classification task 
was equal to 81.23%. In other words, for 81.23% of the diagnosed 
patients, the proposed model was able to predict the 
improvement or deterioration status of a patient after one year 
correctly.  
Estimating HbA1c using CGM and ActiGraph – In the third 
experiment, the RNN model was trained using the combined 
synchronized dataset of CGM and ActiGraph values. Data from 
50 patients were used in the training and test process with 5-fold 
cross-validation. Having the CGM and ActiGraph signals 
concatenated to each other, the dimension of input data was 
[50×1445×9]. Again, 50 epochs were used for the experiment. 
The result showed an average of RMSE=1.673 (σ=0.126). Also, we 
have obtained a classification accuracy of 86.04% in predicting 
the improvement or deterioration classes. 
Estimating HbA1c using the Wide and Deep model – The 
goal of this phase of the study was to evaluate the prediction 
 
 
performance of the wide and deep model that used both the time 
series and shallow demographic and lab test results of the 
patients. The size of input data for the wide part was 
[50×1445×9] and the size for the shallow part was [50×8]. We 
have obtained an RMSE of 1.668 (σ=0.123), which presents a 
slightly improved prediction performance compared to applying 
the wide only part of the data. For the improvement or 
deterioration classification task an accuracy of 86.04% was 
achieved. 
Estimating other biomedical values – In the last experiment, 
we used the proposed model to predict HDL Cholesterol, LDL 
Cholesterol, and Triglyceride changes with similar experimental 
setup as above. The RMSE of 6.220, 10.458, and 18.377 were 
obtained for HDL, LDL, and Triglycerides respectively. Table 1 
shows a summary of the performance of the proposed method 
and the obtained results in different experiments. 
 
 
Table 1: The normalized error rates and prediction 
accuracy of predicted indexes. Index, signal type (C: CGM, 
A: Activity, D: Demographic, L: Lab results), size of input 
data, RMSE are shown. Normalized error rates (RMSE 
divided by Range), and improvement vs. deterioration 
classification accuracy are also shown. 
6 Conclusion  
In this study, we presented a novel method for predicting the 
progression patterns of T2D by combining the wearable sensors 
data with demographic and lab test data of the patients. CGM 
and activity records of a group of T2D patients in a 7 days period 
were synchronized and used as input time-series signals for 
training the deep part of the model (an LSTM RNN network). In 
estimating the HbA1c within one year, an RMSE of 1.668 was 
obtained. We could achieve significantly higher accuracy than 
using only the demographic and lab results, which are 
commonly used in similar studies of diabetes. 
For the binary classification, which can have a significant clinical 
value in the prognosis of the patients’ disease, the accuracies of 
86.04% and 89.21% respectively for HbA1c and Triglycerides 
show the potential of the model in separating the improving and 
deteriorating patients. Using only the CGM signals, an RMSE of 
1.722 was achieved. Moreover, an RMSE of 6.220 for HDL 
cholesterol, 10.458 for LDL cholesterol, and 18.377 for 
Triglyceride were achieved. These results show that the 
proposed model can effectively utilize various types of features 
collected from a patient and achieve an acceptable error rate. 
Since our model relies on balancing the learning information 
from two class of intrinsically independent data types, we expect 
that higher prediction performance will be achievable by fusing 
our current dataset with larger relevant datasets. 
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